Aarey Drugs & Pharmaceuticals Limited (BOM:524412)
79.46
-2.58 (-3.14%)
At close: Aug 21, 2026
BOM:524412 Revenue
Aarey Drugs & Pharmaceuticals had revenue of 463.41M INR in the quarter ending June 30, 2026, a decrease of -54.66%. This brings the company's revenue in the last twelve months to 4.15B, down -7.66% year-over-year. In the fiscal year ending March 31, 2026, Aarey Drugs & Pharmaceuticals had annual revenue of 4.72B, down -0.35%.
Revenue (ttm)
4.15B
Revenue Growth
-7.66%
P/S Ratio
0.55
Revenue / Employee
31.42M
Employees
132
Market Cap
2.26B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 4.72B | -16.74M | -0.35% |
| Mar 31, 2025 | 4.74B | 713.61M | 17.73% |
| Mar 31, 2024 | 4.03B | -163.73M | -3.91% |
| Mar 31, 2023 | 4.19B | -739.78M | -15.01% |
| Mar 31, 2022 | 4.93B | 1.42B | 40.27% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Anlon Healthcare | 2.26B |
| Influx Healthtech | 1.47B |
| Smruthi Organics | 1.12B |
| Kimia Biosciences | 1.12B |
| Panchsheel Organics | 1.08B |
| Resonance Specialties | 1.02B |
| Shree Ganesh Remedies | 989.78M |
| Tyche Industries | 500.33M |